dr. paul chapman on braf and mek inhibitor combination for advanced melanoma
Published 12 years ago • 1.5K plays • Length 1:33Download video MP4
Download video MP3
Similar videos
-
0:44
dr. chapman describes recent melanoma advances
-
1:19
dr. postow on braf and mek inhibitor combination studies in melanoma
-
1:14
dr. chapman on targeted treatments for non-traditional mutations in melanoma
-
2:15
dr. paul chapman explains recent melanoma study
-
2:10
combined treatment with braf and mek inhibitors in metastatic melanomas with braf mutations
-
1:03
dr. chapman describes the vemurafenib clinical trial
-
2:01
dr. paul chapman explains recent melanoma study findings
-
8:47
braf/mek inhibitors in metastatic melanoma
-
9:49
melanoma: nuances of braf/mek combinations in the front line
-
9:43
sequencing dual braf-mek inhibition and immunotherapy
-
1:04
adverse events of braf and mek inhibitors
-
0:54
dr. chapman on vemurafenib combination therapies
-
0:52
dr. kudchadkar on combining braf and mek inhibitors to treat melanoma
-
6:22
braf and mek in melanoma
-
10:08
emerging approaches for braf-mutant metastatic melanoma
-
1:03
dr. wilson on choosing between braf/mek therapies for patients with melanoma
-
2:07
dr. paul chapman explains recent melanoma study findings
-
9:24
anti-pd1 monotherapy or combination with ipi after braf/mek inhibitors in braf-mutant melanoma
-
6:33
treatment of braf-mutant metastatic melanoma